Perirenal fat as a potential marker and therapeutic target for metabolic syndrome: insights from a multicenter randomized controlled trial Authors Yu-Xuan Lou Hua Yang (ORCID: https://orcid.org/0000-0002-7641-2031) Chaochun Zou (ORCID: https://orcid.org/0000-0002-4667-3636) Ke-Rui Zhang Menghuan Li (ORCID: https://orcid.org/0000-0002-4558-7648) Yuqing Zhang (ORCID: https://orcid.org/0000-0002-0235-2486) Tingting Wu (ORCID: https://orcid.org/0000-0003-3437-8899) Wei Sun (ORCID: https://orcid.org/0000-0003-0405-9774) Chuan-li Cheng Jiaming Yang (ORCID: https://orcid.org/0000-0003-1890-9936) Xiangqing Kong (ORCID: https://orcid.org/0000-0002-5433-5557) Yanhui Sheng (ORCID: https://orcid.org/0000-0001-5109-8704) Institutions Nanchang University (CN) Chinese Academy of Sciences (CN) Suzhou Municipal Hospital (CN) Shenzhen Institutes of Advanced Technology (CN) Nanjing Jiangning Hospital (CN) First Affiliated Hospital of Nanchang University (CN) Nanjing Medical University (CN) Publication Details Journal Frontiers in Endocrinology Published 2025-05-23 DOI https://doi.org/10.3389/fendo.2025.1557701 Citations 2 Primary Topic Cardiovascular Disease and Adiposity Type article Field-Weighted Citation Impact 2.78 Explore the Global Research Space Interactive Map